Disclose an Invention

Connect with UIRF

Connect with any of our licensing team members to learn more or discuss your ideas.

View Available Technologies

Attend a Class

Learn about intellectual property, licensing, and commercialization at one of our virtual classes.

Unsure where to start?

Our staff are here to help guide UI innovators who want to commercialize new innovations.

 

Latest Innovations

CRISPR Correction of Myocilin for the Treatment of Glaucoma

CRISPR Correction of Myocilin for the Treatment of Glaucoma

Preventative Therapy for Post-Traumatic Osteoarthritis

Using Single Nucleotide Variations to Diagnose Ovarian Cancer

Method of Treating Periodontitis

News feed

Cardio Diagnostics Holdings Inc Announces Expansion of IP Portfolio with Notice of Allowance of Patent Application

Cardio Diagnostics Holdings, Inc., a pioneering precision cardiovascular medicine company founded by UI faculty Dr. Robert Philibert and UI graduate Dr. Meesha Dogan, today announced that China’s Patent Office has issued a Notice of Allowance to the University of Iowa Research Foundation (“UIRF”) for Chinese Patent Application No. 201780049286.4.

Iowa Lichtenberger Engineering Library receives Patent & Trademark Resource Center designation

The University of Iowa Lichtenberger Engineering Library is now part of a select group of higher education institutions across the country—and only one in Iowa—to be designated a Patent and Trademark Resource Center (PTRC) by the U.S. Patent and Trademark Office (USPTO).

CJ partners with Emmyon to develop ingredients preventing muscle atrophy

South Korean food giant CJ CheilJedang Corp. announced on Tuesday that it has signed a license contract with Emmyon, an University of Iowa biotechnology startup, to utilize Emmyon's various patents regarding ursolic acid, at its headquarters in Jung-gu, Seoul.

Cardio Diagnostics Holdings, Inc. to List on Nasdaq Following Successful Business Combination with Mana Capital Acquisition Corp.

Cardio Diagnostics Holdings, Inc., a pioneering precision cardiovascular medicine company founded by UI faculty Dr. Robert Philibert and UI graduate Dr. Meesha Dogan, today announced the completion of its business combination with Mana Capital Acquisition Corp., a publicly traded special purpose acquisition company.

Lilly to Acquire Akouos for Up to $610M, Expanding Gene Therapy Focus

Eli Lilly has agreed to acquire Akouos for up to $610 million, in a deal intended to expand the buyer’s presence in gene therapy with a focus on treating inner ear disorders. Akouos, which has licensed key technology from the University of Iowa, develops targeted adeno-associated viral (AAV) vector-based gene therapies for conditions that include sensorineural hearing loss, integrating expertise in otology and inner ear drug delivery, as well as gene therapy.

48

New Licenses and options granted to UI technologies

FY2022

188

New patent applications

FY2022

103

New invention disclosures

FY2022